4.8 Article

Aptamer-immobilized bone-targeting nanoparticles in situ reduce sclerostin for osteoporosis treatment

Related references

Note: Only part of the references are listed.
Review Chemistry, Multidisciplinary

Theranostic nanoparticles with disease-specific administration strategies

Peisen Zhang et al.

Summary: Recent advances in theranostic nanoparticles have shown promise in precision medicine, but challenges remain in terms of low bioavailability and biocompatibility. Emerging administration routes for nanomaterials offer potential benefits in bypassing biological barriers and enhancing imaging sensitivity and therapeutic efficacy.

NANO TODAY (2022)

Review Dentistry, Oral Surgery & Medicine

A review on natural teeth whitening

Asma Gasmi Benahmed et al.

JOURNAL OF ORAL BIOSCIENCES (2022)

Article Orthopedics

Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis

Jia Peng et al.

Summary: The study found that bone sclerostin and Dkk-1 were positively correlated with BMD in women with PO, and higher levels of these proteins might predict better bone density, microarchitecture, and strength. Further research is needed to explore the underlying molecular mechanisms.

BMC MUSCULOSKELETAL DISORDERS (2021)

Review Chemistry, Multidisciplinary

Aptamer functionalized nanomaterials for biomedical applications: Recent advances and new horizons

Mansour Mahmoudpour et al.

Summary: This review discusses the design and applications of aptamer functionalized nanomaterials (AFMs) in the biomedical field, including synthesis strategies, versatile roles of nanomaterials, and representative examples of biomedical applications. Challenges and opportunities in this emerging field are also presented.

NANO TODAY (2021)

Review Chemistry, Multidisciplinary

Nanotoxicology and nanomedicine: The Yin and Yang of nano-bio interactions for the new decade

Olesja Bondarenko et al.

Summary: Nanotoxicology and nanomedicine are two sub-disciplines of nanotechnology that focus on nano-bio interface, with shared goals and challenges. In recent years, the relationship between the two fields has become closer, and their joint development can bring greater benefits to human health and environmental safety.

NANO TODAY (2021)

Review Chemistry, Multidisciplinary

Dendritic mesoporous organosilica nanoparticles (DMONs): Chemical composition, structural architecture, and promising applications

Yabin Wang et al.

Summary: Dendritic mesoporous organosilica nanoparticles (DMONs) with unique structural features and biocompatibility have gained increasing attention and development in biochemical applications in recent years.

NANO TODAY (2021)

Article Nanoscience & Nanotechnology

Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19

Zhenhua Li et al.

Summary: The authors demonstrate that nanovesicles coated with lung spheroid cell membranes expressing angiotensin-converting enzyme 2 can bind and neutralize SARS-CoV-2, potentially serving as a therapeutic agent for treating COVID-19.

NATURE NANOTECHNOLOGY (2021)

Article Chemistry, Multidisciplinary

Osteoporosis Remission and New Bone Formation with Mesoporous Silica Nanoparticles

Patricia Mora-Raimundo et al.

Summary: Nanotechnology plays a crucial role in the treatment of osteoporosis by delivering siRNA through mesoporous silica nanoparticles, promoting bone formation and improving bone microarchitecture, effectively treating osteoporosis.

ADVANCED SCIENCE (2021)

Article Nanoscience & Nanotechnology

Alendronate-Decorated Nanoparticles as Bone-Targeted Alendronate Carriers for Potential Osteoporosis Treatment

Chunlan Jing et al.

Summary: Alen-decorated nanoparticles were successfully prepared through ionic cross-linking, showing good cytocompatibility and sustained drug release, making them a promising bone-targeted carrier for osteoporosis treatment.

ACS APPLIED BIO MATERIALS (2021)

Review Endocrinology & Metabolism

Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis

Eben G. Estell et al.

Summary: The mainstay treatment for osteoporosis has traditionally been antiresorptive agents, but declining adherence has led to a plateau in fracture rates reduction. The approval of anabolic agents in the past two decades represents a new approach to improving bone quality and reducing fracture risk, potentially leading to a new clinical paradigm.

NATURE REVIEWS ENDOCRINOLOGY (2021)

Article Endocrinology & Metabolism

A broader strategy for osteoporosis interventions

Ian R. Reid

NATURE REVIEWS ENDOCRINOLOGY (2020)

Article Medicine, Research & Experimental

Bone-Targeting AAV-Mediated Gene Silencing in Osteoclasts for Osteoporosis Therapy

Yeon-Suk Yang et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)

Article Multidisciplinary Sciences

Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis

Yeesuk Kim et al.

SCIENTIFIC REPORTS (2020)

Review Cell Biology

Mechanisms of bone development and repair

Ankit Salhotra et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Article Multidisciplinary Sciences

Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains

Jinuk Kim et al.

NATURE COMMUNICATIONS (2020)

Review Chemistry, Multidisciplinary

Progress, challenges, and future of nanomedicine

Chenyang Zhang et al.

NANO TODAY (2020)

Review Pharmacology & Pharmacy

Romosozumab (sclerostin monoclonal antibody) for the treatment of osteoporosis in postmenopausal women: A review

Ahmad Shakeri et al.

JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY (2020)

Article Endocrinology & Metabolism

The Prevalence of Osteoporosis in China, a Nationwide, Multicenter DXA Survey

Qiang Zeng et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2019)

Review Nanoscience & Nanotechnology

Single-micelle-directed synthesis of mesoporous materials

Tiancong Zhao et al.

NATURE REVIEWS MATERIALS (2019)

Article Biotechnology & Applied Microbiology

Bone-targeting drug delivery system of biomineral-binding liposomes loaded with icariin enhances the treatment for osteoporosis

Xiaoduan Sun et al.

JOURNAL OF NANOBIOTECHNOLOGY (2019)

Article Multidisciplinary Sciences

Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles

Xiaodong Xie et al.

NATURE COMMUNICATIONS (2019)

Review Rheumatology

Update on the safety and efficacy of teriparatide in the treatment of osteoporosis

Salvatore Minisola et al.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2019)

Article Chemistry, Multidisciplinary

Oral Nanoparticles Exhibit Specific High-Efficiency Intestinal Uptake and Lymphatic Transport

Kyoung Sub Kim et al.

ACS NANO (2018)

Review Biotechnology & Applied Microbiology

Aptamers as targeted therapeutics: current potential and challenges

Jiehua Zhou et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Review Engineering, Biomedical

Nanoparticles for the treatment of osteoporosis

P. Mora-Raimundo et al.

AIMS BIOENGINEERING (2017)

Article Pharmacology & Pharmacy

Atorvastatin-loaded micelles with bone-targeted ligand for the treatment of osteoporosis

Yonghui Xie et al.

DRUG DELIVERY (2017)

Article Chemistry, Multidisciplinary

Programmable drug release using bioresponsive mesoporous silica nanoparticles for site-specific oral drug delivery

Amirali Popat et al.

CHEMICAL COMMUNICATIONS (2014)

Article Materials Science, Biomaterials

DNA adsorbed on hydroxyapatite surfaces

Luis J. del Valle et al.

JOURNAL OF MATERIALS CHEMISTRY B (2014)

Article Chemistry, Multidisciplinary

Nanoparticles Mimicking Viral Surface Topography for Enhanced Cellular Delivery

Yuting Niu et al.

ADVANCED MATERIALS (2013)

Article Biochemical Research Methods

Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems

D Wang et al.

BIOCONJUGATE CHEMISTRY (2003)